KLHL17 activators belong to a class of chemical compounds that target and modulate the activity of the KLHL17 protein, which is a member of the Kelch-like family characterized by a series of repeats that form a kelch motif. KLHL17, also known as kelch-like protein 17, is implicated in a variety of cellular processes due to its role in protein-protein interactions. These activators are designed to enhance the function of KLHL17, either by increasing its stability, promoting its interaction with other proteins, or facilitating its localization to specific cellular compartments where it exerts its action. The molecular intricacies of KLHL17 activation are complex, as the process may involve conformational changes in the protein structure that enhance its affinity for partner proteins or substrates, or perhaps the prevention of degradation pathways that would otherwise decrease KLHL17 levels.
The development and characterization of KLHL17 activators require a detailed understanding of the protein's structure and the molecular pathways it is involved in. The activators typically work by binding to the KLHL17 protein at specific sites that are critical for its function. These sites could be located in the kelch domain or other functional domains of the protein, which play a role in its ability to interact with other proteins and execute its functions. By binding to these sites, KLHL17 activators can induce conformational changes that either expose interaction sites or stabilize the protein in a configuration that is more conducive to function.
製品名 | CAS # | カタログ # | 数量 | 価格 | 引用文献 | レーティング |
---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
GSK-3βの阻害剤であり、ユビキチン化と分解を阻害することでタンパク質を安定化させ、間接的にKLHL17のレベルを上昇させる可能性がある。 | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
KLHL17の発現に影響を及ぼす可能性のある、遺伝子の脱メチル化とその後の転写を導く可能性のあるDNAメチル化酵素阻害剤。 | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
ヒストン脱アセチル化酵素阻害剤で、クロマチン構造を変化させることにより遺伝子発現を増加させ、おそらくKLHL17合成の亢進につながる。 | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $70.00 $198.00 | 18 | |
別のGSK-3β阻害剤で、タンパク質の安定性を高め、KLHL17のレベルまたは活性を増強する可能性があります。 | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
ユビキチン化タンパク質の分解を阻害するプロテアソーム阻害剤で、KLHL17を安定化させる可能性がある。 | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
アデニル酸シクラーゼの活性化因子で、細胞内のcAMPレベルを上昇させ、遺伝子発現の変化とKLHL17レベルの上昇を引き起こす可能性がある。 | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 18 | |
ヒストン脱アセチル化酵素阻害剤で、ヒストンのアセチル化を増加させ、クロマチン構造を弛緩させ、KLHL17の発現を増加させる可能性がある。 | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
ROCK阻害剤で、細胞骨格構成に影響を与え、KLHL17が関与する細胞プロセスに影響を与える可能性がある。 |